WebMar 3, 2024 · DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today … WebMar 3, 2024 · About DermTech. DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, …
DermTech Inc.: Buy On Opportunistic Dips (NASDAQ:DMTK)
WebApr 11, 2024 · DermTech’s total covered lives in the U.S. are approximately 126 million, which includes 68 million for Medicare/Medicare Advantage and 58 million for commercial and governmental payers. About The DermTech Melanoma Test DermTech originally marketed its foundational assay under the name Pigmented Lesion Assay (PLA). WebDMTK Stock 12 Months Forecast. $6.50. (100.00% Upside) Based on 2 Wall Street analysts offering 12 month price targets for DermTech in the last 3 months. The average price target is $6.50 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 100.00% change from the last price of $3.25. durban south africa pictures
DermTech to Present at March Investor Conferences - Yahoo Finance
WebFeb 17, 2024 · About DermTech: DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled … WebMar 15, 2024 · LA JOLLA, Calif.--(BUSINESS WIRE)--Apr. 11, 2024-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a Blues plan in North Carolina.The contract, which is in addition to a favorable coverage … WebMar 8, 2024 · DermTech Corporate Presentation 2024 Annual Report Press Releases Mar 14, 2024 DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2024 American Academy of … crypto cartel board game